Related references
Note: Only part of the references are listed.The expression and clinical significance of programmed cell death receptor 1 and its ligand in tumor tissues of patients with extranodal nasal NK/T cell lymphoma
Yu Feng et al.
SCIENTIFIC REPORTS (2022)
Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells
Cedric Pastoret et al.
BLOOD (2021)
Extranodal NK/T cell lymphoma, nasal type: An updated overview
Celeste Sanchez-Romero et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)
Reactive NK cell lymphocytosis with atypical immunophenotype in a chronic HIV-infected patient
Shujuan Liu et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2021)
High IL-6 expression in the tumor microenvironment is associated with poor prognosis of patients with extranodal natural / killer T-cell lymphoma (ENKTL)
Qixiang Rong et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2021)
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
Deborah Blythe Doroshow et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Editorial: HLA and KIR Diversity and Polymorphisms: Emerging Concepts
Martin Maiers et al.
FRONTIERS IN IMMUNOLOGY (2021)
KIR Receptors as Key Regulators of NK Cells Activity in Health and Disease
Joanna Debska-Zielkowska et al.
CELLS (2021)
Immune subtyping of extranodal NK/T-cell lymphoma: a new biomarker and an immune shift during disease progression
Junhun Cho et al.
MODERN PATHOLOGY (2020)
A high definition picture of somatic mutations in chronic lymphoproliferative disorder of natural killer cells
Vanessa Rebecca Gasparini et al.
BLOOD CANCER JOURNAL (2020)
A New Immunological Prognostic Model Based on Immunohistochemistry for Extranodal Natural Killer/T-Cell Lymphoma Patients After Non-Anthracycline-Based Chemotherapy
Sio Teng Lam et al.
CANCER MANAGEMENT AND RESEARCH (2020)
STAT3 and STAT5B Mutations in T/NK-Cell Chronic Lymphoproliferative Disorders of Large Granular Lymphocytes (LGL): Association with Disease Features
Noemi Munoz-Garcia et al.
CANCERS (2020)
Superiority of Epstein-Barr Virus DNA in the Plasma Over Whole Blood for Prognostication of Extranodal NK/T Cell Lymphoma
Joo Young Ha et al.
FRONTIERS IN ONCOLOGY (2020)
T cell large granular lymphocyte leukemia and chronic NK lymphocytosis
Gregorio Barila et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2019)
CD7 CAR T Cells for the Therapy of Acute Myeloid Leukemia
Diogo Gomes-Silva et al.
MOLECULAR THERAPY (2019)
Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma
Jinhyun Cho et al.
ANNALS OF HEMATOLOGY (2018)
Aggressive natural killer (NK)-cell leukaemia and extranodal NK/T-cell lymphoma are two distinct diseases that differ in their clinical presentation and cytogenetic findings
Ching-Fen Yang et al.
HISTOPATHOLOGY (2018)
Cell surface markers for the identification and study of human naive pluripotent stem cells
Oliver Trusler et al.
STEM CELL RESEARCH (2018)
Dysfunctional immunoregulation in human liver allograft rejection associated with compromised galectin-1/CD7 pathway function
Sidong Wei et al.
CELL DEATH & DISEASE (2018)
Dominant cytotoxic NK cell subset within CLPD-NK patients identifies a more aggressive NK cell proliferation
Gregorio Barila et al.
BLOOD CANCER JOURNAL (2018)
The Clinical Utility of Circulating Epstein-Barr Virus DNA Concentrations in NK/T-Cell Lymphoma: A Meta-Analysis
Ze-Long Liu et al.
DISEASE MARKERS (2018)
The utility of flow cytometry in differentiating NK/T cell lymphoma from indolent and reactive NK cell proliferations
Sanjay de Mel et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2018)
CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies
Diogo Gomes-Silva et al.
BLOOD (2017)
PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing L-asparaginase
Yok-Lam Kwong et al.
BLOOD (2017)
Introduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues
Mario Cazzola
BLOOD (2016)
PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma
Xi-wen Bi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Novel CD7-specific nanobody-based immunotoxins potently enhanced apoptosis of CD7-positive malignant cells
Jinle Tang et al.
ONCOTARGET (2016)
CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK/T cell lymphoma, nasal type
Liang Wang et al.
ANNALS OF HEMATOLOGY (2015)
Prognostic implications of CD30 expression in extranodal natural killer/T-cell lymphoma according to treatment modalities
Wook Youn Kim et al.
LEUKEMIA & LYMPHOMA (2015)
CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type
Pengfei Li et al.
BMC CANCER (2014)
Activating KIRs in chronic lymphoproliferative disorder of NK cells: protection from viruses and disease induction?
Renato Zambello et al.
FRONTIERS IN IMMUNOLOGY (2014)
STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia
Andres Jerez et al.
BLOOD (2012)
Quality control by tissue microarray in immunohistochemistry
Sergio Antonio Tripodi et al.
JOURNAL OF CLINICAL PATHOLOGY (2012)
CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells
Kerstin Juelke et al.
BLOOD (2010)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
Quality control in molecular immunohistochemistry
Lawrence D. True
HISTOCHEMISTRY AND CELL BIOLOGY (2008)
CD56bright human NK cells differentiate into CD56dim cells:: Role of contact with peripheral fibroblasts
Antoni Chan et al.
JOURNAL OF IMMUNOLOGY (2007)
The ex vivo patterns of CD2/CD7, CD57/CD11c, CD38/CD11b, CD45RA/CD45RO, and CD11a/HLA-DR expression identify acute/early and chronic/late NK-cell activation states
M Lima et al.
BLOOD CELLS MOLECULES AND DISEASES (2002)
Share Paper
